|
Intervention
From: Health
Sector Reform in Asia and the Pacific – options for developing countries
– Asia Development Bank 1999 |
Prioritization factors |
|
Cost/ DALY ($) |
Evidence of medical efficacy |
Burden Corrects
of disease Market
failure |
Improves equity
|
|
Vector control for dengue using drainage and land
management |
>$1,000
|
1 = Difficult to show benefit
|
Low to moderate |
Yes
|
Yes
|
|
Fetal ultrasound |
Unknown but likely high |
3 = Limited prospective data show no impact on outcome |
Not applicable |
No
|
No
|
|
X-rays for low back pain
|
Unknown but likely high |
4 = Good clinical data show ineffective unless other risk
factors present |
Low |
|
No
|
No
|
|
Evaluation for heart attack |
>41,000
|
4 = Clinical data show surgery effective in subset of
patients |
Low
|
|
No
|
No
|
|
Surgery for cancer |
> $1,000 |
3 = Data show clinical staging critical; outcomes varied |
Low
|
|
No
|
No
|
|
Surgery for coronary artery disease
and rheumatic heart
disease |
>$ 1,000 |
4 = Effective in few patients |
Low to moderate |
No
|
No
|
|
Surgery for leprosy complication |
$75-250 |
2 = Appears effective |
Low |
|
No |
No |
|
Medical treatment of tetanus
|
$75-250
|
3 = Clinical supportive care can be effective |
Low
|
|
No
|
No
|
|
Antibiotic prevention for children
with history of
rheumatic fever |
$75-250 |
1 = Effectiveness difficult to assess |
Low |
|
No
|
No
|